TB Epidemic Continues to Claim Lives Despite Availability of Treatments

The European AIDS Treatment Group has emphasized that Tuberculosis (TB) is a preventable and curable disease, yet it affects over 10 million people worldwide annually. Without immediate action, the human and economic toll of the disease will continue to rise. In 2023, member states committed to mobilizing $5 billion annually by 2027 for TB research and innovation, including diagnostics, vaccines, and drug regimens. The TB epidemic persists due to inadequate funding and insufficient political will.

Key Takeaways:

  • TB is a preventable and curable disease that affects over 10 million people worldwide every year.
  • Member states committed to mobilize $5 billion annually by 2027 for TB research and innovation during the UN High-Level Meeting on TB in 2023.
  • Investing in research and development to improve TB tools is crucial for eradicating the disease.
  • A report by Results Canada and Results UK presents the case for meeting financial targets for TB research and development.
  • TB research offers financial returns, strengthens health systems, builds research capacity, and enhances global health security.
  • Sustainable funding, policy reform, and strong political will are required to bring new innovations to life and reach affected communities.
  • Outdated tools are still relied upon for TB prevention, diagnosis, and treatment, making modern and effective solutions inaccessible to those affected.

Statistics:

  • Over 10 million people worldwide contract TB annually, highlighting the disease's persistent impact.
  • Member states committed to mobilize $5 billion annually by 2027 for TB research and innovation during the UN High-Level Meeting on TB in 2023.
  • Only through investing in research and development can the tools for TB prevention, diagnosis, and treatment be improved.
  • TB research has the potential to generate financial returns, improve health outcomes, and enhance global health security.

Sources:

  • European AIDS Treatment Group
  • UN High-Level Meeting on TB (2023)
  • Results Canada
  • Results UK